Ipamorelin
$59.99
In stockIpamorelin is a synthetic pentapeptide and selective ghrelin-receptor agonist studied for growth-hormone release, receptor selectivity, endocrine signaling, and pharmacokinetic-pharmacodynamic relationships.
| SKU | RC-ST-IPA-10MG |
|---|---|
| Manufacturer | Strandix Peptides |
| Form | Lyophilized Powder |
| Strength | 10 mg |
| Size | 3 mL Vial |
| Reported Result | See matching batch report |
| Stock | In stock |
| Documentation Status | Client-supplied report available |
Ipamorelin is a synthetic pentapeptide developed as a growth-hormone secretagogue. Early pharmacology characterized it as a selective agonist of the growth-hormone-secretagogue receptor, or GHSR1a, with a hormone-release profile that differed from several earlier GHRPs. Research has examined growth-hormone responses, receptor selectivity, gastrointestinal motility, and pharmacokinetic-pharmacodynamic relationships. It is not FDA approved and should not be presented as equivalent to an approved peptide medicine.
Storage and handling: Follow the manufacturer label and matching batch documentation.
Third-party testing status.
| Batch / Lot | Reported Result | Tested | Partner | Status | Document |
|---|---|---|---|---|---|
| IPA10/2025-12-18-B | 99.777%; 99.731% | Jan 5, 2026 | Janoshik | Client-supplied report | View COA |